Clinical trial
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up…
NCT00216879 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00216879 |
|---|---|
| Title | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis |
| Official title | Long-term Treatment of Scalp Psoriasis With Calcipotriol Plus Betamethasone Dipropionate Gel |
| Lead sponsor | LEO Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psoriasis of Scalp |
| Intervention type | Drug |
| Interventions | Calcipotriol plus betamethasone dipropionate gel (LEO 80185) |
| Enrollment | 800 |
| Start date | Feb 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 24, 2025 |
| Countries | Canada, Denmark, France, Germany, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: